Delivery Order SPE2DB24D2010-SPE2DB25FABHR
- Not listed
- The Defense Logistics Agency awarded a $1,377.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count units), with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,144.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 29, 2025. The delivery order was issued on July 28, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.04 to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 26, 2025, and represents performance at the awardee's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 15 mg tablets (100-count) valued at $1,210.93 under a firm fixed price contract type. The order was competitively awarded without set-aside designation and is due for completion by August 6, 2025. AmerisourceBergen will fulfill this delivery from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as one of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 tablets. This contract is a firm fixed price delivery order with a ceiling value of $1,436.91 and an ultimate completion date of September 3, 2025. The award carries no set-aside designation and was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,475.15 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets (100-count) on September 25, 2025, with completion scheduled for September 26, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units, with a contract ceiling value of $3,857.54. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The work will be performed at the...
- The Defense Logistics Agency awarded a $1,518.01 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract is not set-aside and was competitively awarded, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of dextroamphetamine-amphetamine 15 mg tablets in quantities of 100 units, with a contract value of $2,381.06 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a standard pharmaceutical procurement through the federal medical supply chain with no set-aside designation. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $1,316.42 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABHRDelivery Order
The Defense Logistics Agency awarded a $2,819.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg tablets (100-count units). This is a non-set-aside contract with an ultimate completion date of September 24, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order represents a task under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply military healthcare systems and other federal agencies with a broad range of pharmaceutical products and medical supplies. As a competitively awarded prime contractor, AmerisourceBergen demonstrates established capability in fulfilling federal medical supply requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/23/25 |